Investor Status. The Investor acknowledges that it is either (i) an institutional “accredited investor” as defined in Rule 501(a) of Regulation D of the Securities Act (an “Institutional Accredited Investor”) or (ii) a “qualified institutional buyer” as defined in Rule 144A of the Securities Act, as indicated on Schedule A hereto, and the Investor shall submit to the Company such further assurances of such status as may be reasonably requested by the Company.
Appears in 11 contracts
Samples: Common Stock Purchase Agreement (Cytokinetics Inc), Series a Preferred Share Purchase Agreement (Biohaven Pharmaceutical Holding Co Ltd.), Common Stock Purchase Agreement (Cytokinetics Inc)
Investor Status. The Investor acknowledges that it is either (i) an institutional “accredited investor” as such term is defined in Rule 501(a) of Regulation D under the Securities Act, and has such knowledge and experience in financial and business matters that it is capable of evaluating the merits and risks of the Securities Act (an “Institutional Accredited Investor”) or (ii) investment to be made by it hereunder. ComVentures V, L.P. is a “qualified institutional buyer” buyer as defined in Rule 144A of the Securities Act, as indicated on Schedule A hereto, and the Investor shall submit to the Company such further assurances of such status as may be reasonably requested by the Company.144A.
Appears in 3 contracts
Samples: Stock Purchase Agreement (Axesstel Inc), Stock Purchase Agreement (Axesstel Inc), Stock Purchase Agreement (Axesstel Inc)
Investor Status. The Each Investor acknowledges that it is either (i) an institutional “accredited investor” as defined in Rule 501(a) of Regulation D of the Securities Act (an “Institutional Accredited Investor”) or (ii) a “qualified institutional buyer” as defined in Rule 144A of the Securities Act, as indicated on Schedule A hereto, and the each Investor shall submit to the Company such further assurances of such status as may be reasonably requested by the Company.
Appears in 2 contracts
Samples: A Common Stock Purchase Agreement (TerraForm Power, Inc.), Class a Common Stock Purchase Agreement (Brookfield Asset Management Inc.)
Investor Status. The Investor acknowledges that it is either (i) an institutional “accredited investor” as defined in Rule 501(a) of Regulation D of the Securities Act (an “Institutional Accredited Investor”) or (ii) a “qualified institutional buyer” as defined in Rule 144A of the Securities Act, as indicated on Schedule A hereto, and the Investor shall submit to the Company such further assurances of such status as may be reasonably requested by the Company.
Appears in 2 contracts
Samples: Common Stock Purchase Agreement (THC Therapeutics, Inc.), Common Stock Purchase Agreement (THC Therapeutics, Inc.)
Investor Status. The Investor acknowledges that it is either (i) an institutional “accredited investor” as defined in Rule 501(a) of Regulation D of the Securities Act (an “Institutional Accredited Investor”) or (ii) a “qualified institutional buyer” as defined in Rule 144A of the Securities Act, as indicated on Schedule A hereto, and the Investor shall submit to the Company such further assurances of such status as may be reasonably requested by the Company.
Appears in 1 contract
Investor Status. The Investor acknowledges that it is either (i) an institutional “accredited investor” as defined in Rule 501(a) of Regulation D of the Securities Act (an “Institutional Accredited Investor”) or (ii) a “qualified institutional buyer” as defined in Rule 144A of the Securities Act, as indicated on Schedule A hereto, and the Investor shall submit to the Company such further assurances of such status as may be reasonably requested by the Company.
Appears in 1 contract
Samples: Common Stock Purchase Agreement (Biocryst Pharmaceuticals Inc)
Investor Status. The Investor Buyer acknowledges that it is either (i) an institutional “accredited investor” as defined in Rule 501(a) of Regulation D of the Securities Act (an “Institutional Accredited Investor”) or (ii) a “qualified institutional buyer” as defined in Rule 144A of the Securities Act, as indicated on Schedule A hereto, and the Investor shall submit to the Company such further assurances of such status as may be reasonably requested by the Company.
Appears in 1 contract
Samples: Development Funding Bond Purchase Agreement (MorphoSys AG)
Investor Status. The Investor acknowledges that it is either (i) an institutional “"accredited investor” " as defined in Rule 501(a) of Regulation D of the Securities Act (an “"Institutional Accredited Investor”") or (ii) a “"qualified institutional buyer” " as defined in Rule 144A of the Securities Act, as indicated on Schedule SCHEDULE A hereto, and the Investor shall submit to the Company such further assurances of such status as may be reasonably requested by the Company.
Appears in 1 contract
Investor Status. The Investor acknowledges that it is either (i) an institutional “accredited investor” as defined in Rule 501(a) of Regulation D of the Securities Act (an “Institutional Accredited Investor”) or (ii) a “qualified institutional buyerInvestor” as defined in Rule 144A of the Securities Act, as indicated on Schedule A hereto, and the Investor shall submit to the Company such further assurances of such status as may be reasonably requested by the Company.
Appears in 1 contract
Samples: Purchase Agreement (Epizyme, Inc.)
Investor Status. The Investor acknowledges that it is either (i) an institutional “accredited investor” as defined in Rule 501(a) of Regulation D of the Securities Act (an “Institutional Accredited Investor”) or (ii) a “qualified institutional buyer” as defined in Rule 144A of the Securities Act, as indicated on Schedule A hereto, and the Investor shall submit to the Company such further assurances of such status as may be reasonably requested by the Company.
Appears in 1 contract
Samples: Common Stock Purchase Agreement (Mirum Pharmaceuticals, Inc.)
Investor Status. The Investor acknowledges that it is either (i) an institutional “accredited investor” as defined in Rule 501(a) of Regulation D of the Securities Act (an “Institutional Accredited Investor”) or (ii) a “qualified institutional buyer” as defined in Rule 144A of the Securities Act, as indicated on Schedule A B hereto, and the Investor shall submit to the Company such further assurances of such status as may be reasonably requested by the Company.
Appears in 1 contract
Samples: Series B Preferred Share Purchase Agreement (Biohaven Pharmaceutical Holding Co Ltd.)
Investor Status. The Investor acknowledges that it is either (i) an institutional “accredited investor” as defined in Rule 501(a) of Regulation D of the Securities Act (an “Institutional Accredited Investor”) or (ii) a “qualified institutional buyer” as defined in Rule 144A of the Securities Act, as indicated on Schedule A hereto, and the Investor shall submit to the Company such further assurances of such status as may be reasonably requested by the Company).
Appears in 1 contract
Samples: Common Stock Purchase Agreement (Eiger BioPharmaceuticals, Inc.)
Investor Status. The Investor acknowledges that it is either (i) an institutional “accredited investor” as defined in Rule 501(a) of Regulation D of the Securities Act (an “Institutional Accredited Investor”) or (ii) a “qualified institutional buyer” as defined in Rule 144A of the Securities Act, as indicated on Schedule A hereto, and the Investor shall submit to the Company such further assurances of such status as may be reasonably requested by the Company.
Appears in 1 contract
Samples: Common Stock Purchase Agreement (TerraForm Power, Inc.)
